NSCLC, STAGE III
Clinical trials for NSCLC, STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE III trials appear
Sign up with your email to follow new studies for NSCLC, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail lung cancer patients: targeted drug shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called repotrectinib in 30 frail or elderly patients with advanced lung cancer that has a specific genetic change (ROS1). The goal is to see if the drug can shrink tumors and be well-tolerated in this group, who are often left out of other trials. Part…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
New drug cocktail shows promise for shrinking lung tumors before surgery
Disease control Recruiting nowThis study is for people with stage II or III non-small cell lung cancer who are scheduled for surgery. It tests whether giving a combination of two immunotherapy drugs (sintilimab and IBI310) plus chemotherapy before surgery can shrink tumors more effectively. The goal is to see…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Hormone-Immuno combo takes on advanced lung cancer
Disease control Recruiting nowThis study tests whether adding a hormone therapy (leuprorelin) to an immunotherapy (sintilimab) can help control advanced lung cancer in men aged 60 or older. The hormone therapy may rejuvenate the immune system to make the immunotherapy work better. The trial will measure tumor…
Matched conditions: NSCLC, STAGE III
Phase: NA • Sponsor: Jinzhou Medical University • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Blood test guides stronger combo therapy for advanced lung cancer
Disease control Recruiting nowThis study is for people with stage III non-small cell lung cancer that cannot be removed by surgery. Researchers want to see if adding another immunotherapy drug (tremelimumab) and extra chemotherapy to the standard drug (durvalumab) can lower the amount of cancer DNA found in t…
Matched conditions: NSCLC, STAGE III
Phase: PHASE3 • Sponsor: Maximilian Diehn • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Can tailored workouts help lung cancer patients? new study aims to find out
Symptom relief Recruiting nowThis study tests whether a personalized exercise program, delivered through telehealth, is practical for people with stage II or III lung cancer who are receiving treatments like chemotherapy or immunotherapy. Researchers will track how many patients join and stick with the progr…
Matched conditions: NSCLC, STAGE III
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC